Presbyopia Pipeline Assessment | In-depth Analysis into the Clinical Trials, Latest Regulatory Approvals, Emerging Drugs, and Growth Prospects | Key Companies – Allergan, Novartis, Eyenovia, AbbVie

August 04 18:30 2022
Presbyopia Pipeline Assessment | In-depth Analysis into the Clinical Trials, Latest Regulatory Approvals, Emerging Drugs, and Growth Prospects | Key Companies - Allergan, Novartis, Eyenovia, AbbVie
Delveinsight Business Research LLP
Current clinical management of Presbyopia includes off-label treatment such as nonsteroidal anti-inflammatory drugs (NSAIDs), parasympathetic agonists, miotic agents, or some other tempering agents. The most commonly used agents are Pilocarpine, Carbachol, Aceclidine, Brimonidine, Nepafenac, etc.

As per DelveInsight, the Presbyopia Therapeutics Market dynamics are expected to transform in the coming years owing to the launch of emerging therapies, ongoing Research and Development (R&D) activities, the rise in the number of Prevalent cases of Presbyopia, and the active participation of the global pharma and biotech giants in the therapeutic segment. Several key companies are active in the therapeutic domain, and the therapies under development are focused on novel approaches to treat/improve the disease.

“Presbyopia Pipeline Insight, 2022″ report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Presbyopia Market. 

The Presbyopia Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers, acquisition, funding, designations, and other product-related details.

Presbyopia Pipeline Analysis

The report provides insights into: 

  • The report provides detailed insights about companies that are developing therapies for the treatment of Presbyopia with aggregate therapies developed by each company for the same.

  • It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for the Presbyopia Treatment.

  • Presbyopia key companies involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.

  • Presbyopia Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type. 

  • Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement, and financing details for future advancement of the Presbyopia market.

The report is built using data and information traced from the researcher’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.  

Request for Sample PDF Report –

Presbyopia Therapeutics Landscape

The Presbyopia market dynamics are anticipated to change in the coming years owing to the launch of the emerging pipeline, the growth in healthcare spending, and the rise in awareness worldwide.

Some of the key Companies in the Presbyopia market include:

  • Allergan 

  • Novartis

  • Eyenovia

  • AbbVie

  • Regeneron 

  • Amgen

  • Novartis

  • Ocuphire Pharma

And many others.

Presbyopia Drugs Covered in the Report Include:

  • AGN-190584

  • MicroLine (Pilocarpine Ophthalmic)

  • PresbiDrops (CSF-1)

  • UNR844 (Lipoic acid cholineester)

  • Nyxol (Phentolamine Mesylate)

  • VTI-001 (Brimochol)

  • AGN-241622

And many more.

Get More Detailed Insights Into the Emerging Therapies & Key Companies –

Table of Content (TOC)

1. Report Introduction

2. Executive Summary

3. Presbyopia Current Treatment Patterns

4. Presbyopia – DelveInsight’s Analytical Perspective

5. Therapeutic Assessment

6. Presbyopia Late Stage Products (Phase-III)

7. Presbyopia Mid-Stage Products (Phase-II)

8. Presbyopia Early Stage Products (Phase-I)

9. Pre-clinical Products and Discovery Stage Products

10. Inactive Products

11. Dormant Products

12. Presbyopia Discontinued Products

13. Presbyopia Product Profiles

14. Key Companies in the Presbyopia Market

15. Key Products in the Presbyopia Therapeutics Segment

16. Dormant and Discontinued Products

17. Presbyopia Unmet Needs

18. Presbyopia Future Perspectives

19. Presbyopia Analyst Review  

20. Appendix

21. Report Methodology

*The Table of Contents (TOC) is not exhaustive; the final content may vary. Refer to the sample report for the complete table of contents.

Download Sample PDF Report –

About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.


Other Trending Healthcare Reports by DelveInsight

Molecular Diagnostics Market
“Molecular Diagnostics Market” research report provides comprehensive insights into the historical and forecasted market size, share, trends, and growth estimation for Molecular Diagnostics. It also covers the latest breakthroughs, collaboration, latest innovations, emerging devices, and key companies working in the global Molecular Diagnostics market. 

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States